Filter
2571
Filtered Results: 2571
Text search:
drug
adherence
Featured
Recommendations
246
New Publications
690
Language
Document type
No document type
1628
Guidelines
364
Studies & Reports
311
Manuals
104
Strategic & Response Plan
80
Fact sheets
32
Training Material
31
Situation Updates
9
Infographics
7
Resource Platforms
4
Brochures
1
Countries / Regions
India
153
Kenya
101
South Africa
80
Tanzania
67
Global
64
Western and Central Europe
64
Uganda
64
Ethiopia
63
Zambia
50
Nigeria
49
Malawi
48
Ghana
40
Namibia
37
Latin America and the Carribbean
36
Nepal
34
Eastern Europe
33
Liberia
33
Sierra Leone
31
Africa
31
Rwanda
29
Lesotho
25
Myanmar / Burma
25
Zimbabwe
24
Asia
19
Bangladesh
19
Ukraine
18
Botswana
18
Cambodia
16
South–East Asia Region
15
Philippines
14
Russia
14
Colombia
11
Mozambique
11
East and Southern Africa
9
Argentina
9
Eswatini/ Swaziland
9
Congo, Democratic Republic of
7
West and Central Africa
7
Brazil
7
Georgia
7
Indonesia
7
Syria
6
Albania
6
USA
6
El Salvador
5
Chile
5
Cameroon
5
Senegal
5
Peru
5
Haiti
5
Eastern Europe and Central Asia
5
Thailand
4
Burkina Faso
4
Armenia
4
Western Pacific Region
4
United Kingdom
4
Sri Lanka
4
Sudan
4
Pakistan
4
Timor Leste/ East Timor
3
Benin
3
China
3
Afghanistan
3
Guinea
3
Jordan
3
Germany
3
North America
3
Jamaica
3
Vietnam
3
Bhutan
3
South Sudan
3
North Macedonia
2
Tajikistan
2
Estonia
2
Venezuela
2
Middle East and North Africa
2
Paraguay
2
Bolivia
2
Ecuador
2
North Korea
1
Turkey
1
Australia
1
Gambia
1
Canada
1
Singapore
1
Laos
1
Qatar
1
Dominican Republic
1
Hungary
1
Saudi Arabia
1
Uruguay
1
Denmark
1
Belgium
1
France
1
Portugal
1
Spain
1
Belarus
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Lebanon
1
Nicaragua
1
Moldova
1
Romania
1
Central African Republic
1
Poland
1
Honduras
1
Angola
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1013
Clinical Guidelines
252
Public Health
123
Women & Child Health
82
Key Resources
53
Capacity Building
47
Pharmacy & Technologies
26
Toolboxes
HIV
451
TB
400
Mental Health
175
AMR
99
NCDs
80
COVID-19
72
Pharmacy
71
NTDs
66
Caregiver
47
Malaria
44
Rapid Response
24
Refugee
24
Ebola & Marburg
19
Conflict
19
Polio
13
Disability
12
Global Health Education
11
Planetary Health
9
Natural Hazards
7
2.0 Rapid Response
5
Cholera
4
Social Ethics
4
Health Financing Toolbox
4
Specific Hazards
3
Zika
2
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
The most frequent health problems of newly arrived refugees and migrants include accidental injuries, hypothermia, burns, gastrointestinal illnesses, cardiovascular events, pregnancy- and delivery-related complications, diabetes and hypertension. Female refugees and migrants frequently face specific...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio...
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is ...
The document “Malaria Prophylaxis for Travellers: Guideline for Healthcare Workers” (2019) from Sri Lanka provides guidance for healthcare providers on preventing malaria among travelers to endemic areas.
It explains that since Sri Lanka was certified malaria-free in 2016, the main risk comes f...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Rappart sur les populations clés.
Zambia Essential Medicines List (ZEML) 05
recommended
2020 Version
